S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

AUPH Aurinia Pharmaceuticals Inc

9.03

-0.01 (-0.11%)

Dec 20 2024 - Closed

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Aurinia Pharmaceuticals Charts.

Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Aurinia Pharmaceuticals Charts.

Aurinia Pharmaceuticals Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Monday 25 November 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 25 November 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 25 November 2024 (4 weeks ago) • Edgar (US Regulatory)

Aurinia Commends 2024 Updated ACR Guidelines for Screening, Treatment, and Management of Lupus Nephritis
Monday 18 November 2024 (1 month ago) • Business Wire

Aurinia Presents New Data Underscoring Critical Importance of Earlier Lupus Nephritis Detection and Intervention and Value of LUPKYNIS® in Managing LN at American College of Rheumatology Convergence 2024
Friday 15 November 2024 (1 month ago) • Business Wire

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Aurinia to Participate in Jefferies London Healthcare Conference
Thursday 14 November 2024 (1 month ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 12 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Tuesday 12 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 7 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 7 November 2024 (1 month ago) • Edgar (US Regulatory)

Aurinia Pharmaceuticals Appoints Craig Johnson to Board of Directors to Support Next Phase of Growth
Thursday 7 November 2024 (1 month ago) • Business Wire

More Aurinia Pharmaceuticals Inc News Articles

Asia Broadband (PK)

Digital Brand Media and ... (PK)

Lightwave Logic

Elite Pharmaceuticals (QB)

Anavex Life Sciences

North Bay Resources (PK)

Good Vibrations Shoes (PK)

Kraig Biocraft Laborator... (QB)

Bioelectronics (PK)

Northwest Biotherapeutics (QB)

Rennova Health (CE)

Fannie Mae (QB)

Code Green Apparel (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions